Zoledronate activates NK cells

Blood

Volumn 118, Issue 10, 2011, Pages 2642-2643

  Yu, Jianhua ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; ISOPRENOID; MEVALONIC ACID; ZOLEDRONIC ACID;

ACCESSORY CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; BONE METASTASIS; CELL ACTIVATION; CELL INFILTRATION; CELL INTERACTION; CELL TYPE; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; INNATE IMMUNITY; MULTIPLE MYELOMA; NATURAL KILLER CELL; NOTE; OSTEOPOROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; VIRUS INFECTION;

EID: 80052653244     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-362707     Document Type: Note

References (8)

1. Cohen MH, Dagher R, Griebel DJ, et al. US Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid. Oncologist. 2002;7(5):393-400.
2. Nussbaumer O, Gruenbacher G, Gander H, ThurnherM. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by gammadeltaTlymphocytes cells Blood. 2011;118(10): 2743-2751.
3. Caligiuri MA. Human natural killer cells. Blood. 2008; 112(3):461-469.
4. Gruenbacher G, Gander H, Nussbaumer O, Nussbaumer W, Rahm A, Thurnher M. IL-2 costimulation enables statin-mediated activation of humanNKcells, preferentially through a mechanism involving CD56+ dendritic cells. Cancer Res. 2010;70(23):9611-9620.
5. Maniar A, Zhang X, Lin W, et al. Human gammadelta Tlymphocytes induce robustNKcell-mediated antitumor cytotoxicity through CD137 engagement. Blood. 2010; 116(10):1726-1733.
6. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5): 503-510. (Pubitemid 351560519)
7. Mocchegiani E, Malavolta M. NK and NKT cell functions in immunosenescence. Aging Cell. 2004;3(4): 177-184.
8. Pontillo A, Paoluzzi E, Crovella S. The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency. Eur J Hum Genet. 2010;18(7):844-847.